Form 4: Orthofix Medical Inc. Director Alan Lee Bazaar Acquires and Disposes of Shares

Director Alan Lee Bazaar reports acquisition and disposal of Orthofix Medical Inc. common stock and deferred stock units.

Summary

• On January 31, 2024, Alan Lee Bazaar, a director of Orthofix Medical Inc., acquired 8,936 shares of common stock at a price of $13.89 per share.
• Simultaneously, Mr. Bazaar disposed of 8,936 shares of common stock.
• The filing also indicates that Mr. Bazaar beneficially owns 8,936 deferred stock units, which vest on the earlier of June 30, 2024, or the date of the 2024 annual meeting of stockholders, contingent upon continued service.
• These vested deferred stock units will convert into common stock within 45 days of termination of service.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it simply reports stock transactions by a director, which is a routine occurrence. There is no indication of positive or negative implications for the company.

Future Outlook

The deferred stock units will vest on the earlier of June 30, 2024, or the date of the 2024 annual meeting of stockholders, subject to the reporting person's service through such date, and will convert into common stock within 45 days of termination of service.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, which is common in the medical device industry. It provides transparency to investors regarding the actions of company leadership.

Comparison to Industry Standards

• Stock ownership and trading activity by directors are common and closely monitored in publicly traded companies, including those in the medical device sector like Medtronic, Stryker, and Johnson & Johnson.
• These companies also have similar reporting requirements for insider transactions to ensure transparency and compliance with SEC regulations.
• The vesting schedules and terms of deferred stock units are also standard compensation practices in the industry to align management's interests with those of shareholders.

Stakeholder Impact

• The stock transactions by a director can influence investor sentiment, but the impact is likely to be minimal unless the transactions are substantial or indicative of a larger trend.

Key Dates